# Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.

> **NCT06052995** · — · UNKNOWN · sponsor: **MEDA PHARMA SPA, a Viatris company** · enrollment: 130 (estimated)

## Conditions studied

- Mild to Moderate Atopic Dermatitis

## Interventions

- **DRUG:** Elidel 1% Topical Cream

## Key facts

- **NCT ID:** NCT06052995
- **Lead sponsor:** MEDA PHARMA SPA, a Viatris company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2024-08
- **Final completion:** 2025-02
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06052995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06052995, "Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06052995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*